Ingrasciotta, Ylenia
 Distribuzione geografica
Continente #
EU - Europa 2.729
NA - Nord America 2.517
AS - Asia 1.324
SA - Sud America 479
Continente sconosciuto - Info sul continente non disponibili 142
AF - Africa 41
OC - Oceania 2
Totale 7.234
Nazione #
US - Stati Uniti d'America 2.440
RU - Federazione Russa 1.522
SG - Singapore 501
BR - Brasile 400
IE - Irlanda 323
CN - Cina 322
SE - Svezia 250
IT - Italia 205
VN - Vietnam 176
HK - Hong Kong 134
DE - Germania 111
PL - Polonia 85
FR - Francia 57
GB - Regno Unito 46
IN - India 46
CA - Canada 34
AR - Argentina 32
BD - Bangladesh 23
FI - Finlandia 22
MX - Messico 19
NL - Olanda 19
IQ - Iraq 15
RO - Romania 15
TR - Turchia 14
BE - Belgio 13
JP - Giappone 13
UA - Ucraina 13
AT - Austria 12
UZ - Uzbekistan 12
EC - Ecuador 11
VE - Venezuela 11
ID - Indonesia 10
MA - Marocco 10
CO - Colombia 9
ES - Italia 8
PK - Pakistan 7
ZA - Sudafrica 7
AZ - Azerbaigian 5
BO - Bolivia 5
EG - Egitto 5
JM - Giamaica 5
KE - Kenya 5
LT - Lituania 5
CI - Costa d'Avorio 4
CR - Costa Rica 4
KZ - Kazakistan 4
PY - Paraguay 4
BY - Bielorussia 3
CH - Svizzera 3
CL - Cile 3
CZ - Repubblica Ceca 3
IR - Iran 3
JO - Giordania 3
KG - Kirghizistan 3
MY - Malesia 3
NI - Nicaragua 3
SA - Arabia Saudita 3
SV - El Salvador 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
LY - Libia 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
TH - Thailandia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CY - Cipro 1
DZ - Algeria 1
GE - Georgia 1
HR - Croazia 1
KR - Corea 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
TJ - Tagikistan 1
TV - Tuvalu 1
Totale 7.091
Città #
Ashburn 535
Moscow 441
Chandler 324
Dublin 323
Singapore 255
Dallas 206
San Jose 177
Nyköping 140
Hong Kong 133
Dong Ket 106
Beijing 93
Warsaw 80
Messina 76
Council Bluffs 68
Los Angeles 65
The Dalles 53
Princeton 51
Medford 42
Munich 40
São Paulo 38
Lauterbourg 37
New York 36
Ann Arbor 32
Bremen 30
Des Moines 26
Santa Clara 26
Redondo Beach 24
Frankfurt am Main 23
Ho Chi Minh City 23
Jacksonville 18
Rome 18
Tianjin 18
Milan 17
Orem 17
Boardman 16
Phoenix 16
Focsani 15
Belo Horizonte 14
Houston 14
Rio de Janeiro 14
Washington 14
Brussels 13
Montreal 12
Tashkent 12
Tokyo 12
Buffalo 11
Chicago 11
Cambridge 10
Curitiba 10
Dearborn 10
Lawrenceville 10
Wilmington 10
Atlanta 9
Brooklyn 9
Campinas 9
Chennai 9
Guangzhou 9
Hanoi 9
Helsinki 9
Jakarta 9
Falls Church 8
London 8
Nuremberg 8
Pune 8
Amsterdam 7
Brasília 7
Baghdad 6
Denver 6
Haiphong 6
Manchester 6
Mexico City 6
Ningbo 6
Baku 5
Bauru 5
Caltagirone 5
Columbus 5
Jinan 5
Juiz de Fora 5
Nairobi 5
Newark 5
Seattle 5
Shanghai 5
Shenyang 5
Shenzhen 5
Suffern 5
Abidjan 4
Campos dos Goytacazes 4
Casablanca 4
Da Nang 4
Ipatinga 4
Johannesburg 4
La Paz 4
Lancaster 4
Medellín 4
Mumbai 4
Nanchang 4
Nanjing 4
Palermo 4
Philadelphia 4
Piracicaba 4
Totale 4.094
Nome #
1. Real World Evidence vs. Real World Data: definizioni e razionale 274
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study 262
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study 242
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study 198
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study 192
Analgesic drug use in elderly persons: A population-based study in Southern Italy 191
Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset 189
Psoriasis and psoriasiform reactions secondary to Immune Checkpoint Inhibitors 187
12. Real World Evidence nelle valutazioni post‑marketing su farmaci generici e biosimilari 175
How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016 173
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? 170
Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study 169
Challenges in Post-marketing Studies of Biological Drugs in the Era of Biosimilars: A Report of the International Society for Pharmacoepidemiology 2019 Mid-Year Meeting in Rome, Italy 168
Real world use of antidiabetic drugs in the years 2011–2017: A population-based study from Southern Italy 167
Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy 162
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project 159
Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy 153
Kidney disease in diabetic patients: From pathophysiology to pharmacological aspects with a focus on therapeutic inertia 153
Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials 153
Biosimilars in Italy: What do real-world data reveal? 152
Erratum: In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study (BMC Nephrology (2019) 20 (359) DOI: 10.1186/s12882-019-1554-0) 151
Neoplastic implications in patients suffering from hidradenitis suppurativa under systemic treatments 148
Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy 147
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 147
Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease 146
Characteristics and Absolute Survival of Metastatic Colorectal Cancer Patients Treated With Biologics: A Real-World Data Analysis From Three European Countries 145
Incidence of Skin Cancer in Patients With Chronic Inflammatory Cutaneous Diseases on Targeted Therapies: A Systematic Review and Meta-Analysis of Observational Studies 141
Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease 140
Antidepressants and the Risk of Cardiovascular Events in Elderly Affected by Cardiovascular Disease: A Real-Life Investigation From Italy 138
The economic burden of preventable adverse drug reactions: a systematic review of observational studies 131
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study 130
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014 125
Medication is an additional source of phosphate intake in chronic kidney disease patients 124
Pharmacokinetics of new oral anticoagulants: implications for use in routine care 122
How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009–2014 117
Safety of Biologics, Including Biosimilars: Perspectives on Current Status and Future Direction. 113
The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy 112
Hidradenitis suppurativa and psoriasis: the odd couple 106
Hidradenitis Suppurativa in Patients with HIV: A Scoping Review 104
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand? 104
Epidemiological analysis to identify predictors of X-linked hypophosphatemia (XLH) diagnosis in an Italian pediatric population: the EPIX project 100
The advent of biosimilars for the treatment of diabetes: current status and future directions 96
Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo 95
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013 94
Interchangeability of biosimilar and biological reference product: updated regulatory positions and pre- and post-marketing evidence. 92
Recent advances in the management of chemotherapy-induced neutropenia: Biosimilar granulocyte colony-stimulating factor use in Italy 88
Non-Motherhood between Obligation and Choice: Statistical Analysis Based on Permutation Tests of Spontaneous and Induced Abortion Rates in the Italian Context 87
Quanto sono utilizzati in Italia i farmaci biosimilari? Uno studio retrospettivo sull'uso degli agenti stimolanti l'eritropoiesi negli anni 2009-2013 86
Safety and potential interaction of immunosuppressive drugs for the treatment of inflammatory bowel disease in elderly patients 73
null 37
null 28
null 24
null 19
null 18
null 17
Totale 7.234
Categoria #
all - tutte 27.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.117


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022353 0 0 0 4 16 8 46 5 24 83 33 134
2022/2023945 71 107 37 89 79 94 14 37 378 5 24 10
2023/2024292 17 30 27 31 30 93 15 5 3 14 1 26
2024/20251.110 26 14 19 63 56 44 45 217 264 96 104 162
2025/20263.519 214 219 258 220 323 717 369 488 443 159 56 53
2026/2027422 56 143 181 42 0 0 0 0 0 0 0 0
Totale 7.234